US Patent 12128102 Constrained conditionally activated binding proteins
Patent 12128102 was granted and assigned to Takeda Pharmaceutical Company on October, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12128102 Constrained conditionally activated binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.